Protein transport across hydrated hyaluronic acid ester membranes: Evaluation of ribonuclease A as a potentially useful model protein

Journal of Controlled Release

Volumn 45, Issue 3, 1997, Pages 273-285

  Simon, L D ^a   Charman, W N ^b   Charman, S A ^b   Stella, V J ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Hyaluronic acid esters; Permeability; Polymer membranes; Protein stability; Ribonuclease A

Indexed keywords

HYALURONIC ACID; HYALURONIC ACID DERIVATIVE; POLYMER; RIBONUCLEASE A;

DIFFUSION; ENZYME STABILITY; ESTERIFICATION; EVAPORATION; MEMBRANE PERMEABILITY; PRIORITY JOURNAL; PROTEIN STABILITY; PROTEIN TRANSPORT; REVIEW; TECHNIQUE;

EID: 0031040226     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(96)01593-3     Document Type: Article

References (41)

1. M. Danckwerts and A. Fassihi, Implantable controlled release drug delivery systems: a review. Drug Dev. Ind. Pharm. 17 (1991) 1465-1502.
2. J. Heller, Chemically self-regulated drug delivery systems, J. Control. Rel. 8 (1988) 111-125.
3. R. Langer and M. Moses, Biocompatible controlled release polymers for delivery of polypeptides and growth factors, J. Cell. Biochem. 45 (1991) 340-345.
4. C. Pitt, The controlled parenteral delivery of polypeptides and proteins, Int. J. Pharm. 59 (1990) 173-196.
5. S. Cohen, T. Yoshioka, M. Lucarelli, L. Hwang and R. Langer, Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres, Pharm. Res. 8 (1991) 713-720.
6. N. Katayama, R. Tanaka, Y. Ohno, C. Ueda, T. Houjou and K. Takada, Implantable slow release cyclosporin A (CYA) delivery system to thoracic lymph duct, Int. J. Pharm. 115 (1995) 87-93.
7. I. Soriano, M. Llabres and C. Evora, Release control of albumin from polylactic acid microspheres, Int. J. Pharm. 125 (1995) 223-230.
8. D. Hsieh, W. Rhine and R. Langer, Zero-order controlled-rcleasc polymer matrices for micro- and macromolecules, J. Pharm. Sci. 72 (1983) 17-22.
9. R. Siegel and R. Langer, Mechanistic studies of macro-molecular drug release from macroporous polymers. II. Models for the slow kinetics of drug release, J. Control. Rel. 14 (1990) 153-167.
10. W. Rhine, D. Hsieh and R. Langer, Polymers for sustained macromolecule release: procedures to fabricate reproducible delivery systems and control release kinetics, J. Pharm. Sci. 69 (1980) 265-270.
11. A. Domb, G. Raymond Davidson III and L. Sanders, Diffusion of peptides through hydrogel membranes, J. Control. Rel. 14 (1990) 133-144.
12. C. Brazel and N. Peppas, Pulsatile local delivery of thrombolytic and antithrombotic agents using poly(N-iso-propylacrylamide-co-methacrylic acid) hydrogels, J. Control. Rel. 39 (1996) 57-64.
13. A. Serres, M. Baudyoš and S. Kim, Temperature and pH-sensitive polymers for human calcitonin delivery, Pharm. Res. 13 (1996) 196-201.
14. R. Langer, Polymer implants for drug delivery in the brain, J. Control. Rel. 16 (1991) 53-60.
15. N. Peppas and J. Scott, Controlled release from poly(vinyl alcohol) gels prepared by freezing-thawing processes, J. Control. Rel. 18 (1992) 95-100.
16. B. Ficek and N. Peppas, Novel preparation of poly(vinyl alcohol) microparticles without crosslinking agent for controlled drug delivery of proteins, J. Control. Rel. 27 (1993) 259-264.
17. R. Linhardt, H. Rosen and R. Langer, Bioerodible polyanhydrides for controlled drug delivery, Polym. Prepr. Am. Chem. Soc. Div. Polym. Chem. 24 (1983) 47-48.
18. Y. Tabata, S. Gutta and R. Langer, Controlled delivery systems for proteins using polyanhydride microspheres, Pharm. Res. 10 (1993) 487-496.
19. J. Heller, A. Chang, G. Rodd and G. Grodsky, Release of insulin from pH-sensitive poly(ortho esters), J. Control. Rel. 13 (1990) 295-302.
20. J. Heller, D. Penhale and B. Fritzinger, A bioerodible self-regulated insulin delivery device, Proc. Int. Symp. Control. Rel. Bioact. Mater. 13 (1985) 37-38.
21. W. Hennink, H. Talsma, J. Borchert, S. De Smedt and J. Demeester, Controlled release of proteins from dextran hydrogels, J. Control. Rel. 39 (1996) 47-55.
22. D. Gilbert, T. Okano, T. Miyata and S. Kim, Macromolecular diffusion through collagen membranes, Int. J. Pharm. 47 (1988) 79-88.
23. L. Di Silvio, N. Gurav, M. Kayser, M. Braden and S. Downes, Biodegradable microspheres: a new delivery system for growth hormone, Biomaterials 15 (1994) 931-936.
24. Y. Tabata, S. Hijikata and Y. Ikada, Enhanced vascularization and tissue granulation by basic fibroblast growth factor impregnated in gelatin hydrogels, J. Control. Rel. 31 (1994) 189-199.
25. R. Cortivo, P. Brun, A. Rastrelli and G. Abatangelo, In vitro studies on biocompatibility of hyaluronic acid esters, Biomaterials 12 (1991) 727-730.
26. E. Ghezzo, L. Benedetti, M. Rochira, F. Biviano and L. Callegaro, Hyaluronane derivative microspheres as NGF delivery devices: preparation methods and in vitro release characterization, Int. J. Pharm. 87 (1992) 21-29.
27. L. Illum, N. Farraj, A. Fisher, I. Gill, M. Miglietta and L. Benedetti, Hyaluronic acid ester microspheres as a nasal delivery system for insulin, J. Control. Rel. 29 (1994) 133-141.
28. D. Papini, V. Stella and E. Topp, Diffusion of macromolecules in membranes of hyaluronic acid esters, J. Control. Rel. 27 (1993) 47-57.
29. P. Prisell, O. Camber, J. Hiselius and G. Norstedt, Evaluation of hyaluronan as a vehicle for peptide growth factors, Int. J. Pharm. 85 (1992) 51-56.
30. J. Richardson, P. Ramires, M. Miglietta, M. Rochira, L. Bacelle, L. Callegaro and L. Benedetti, Novel vaginal delivery systems for calcitonin: I. Evaluation of HYAFF/calcitonin microspheres in rats. Int. J. Pharm. 115 (1995) 9-15.
31. E. Crook, A. Mathias and B. Rabin, Spectrophotometric assay of bovine pancreatic ribonuclease by the use of cytidine 2′:3′-phosphate, Biochem. J. 74 (1960) 234-238.
32. J. Hunt, H. Joshi, V. Stella and E. Topp, Diffusion and drug release in polymer films prepared from ester derivatives of hyaluronic acid, J. Control. Rel. 12 (1990) 159-169.
33. V. Sarin, S. Kent, J. Tam and R. Merrifield, Quantitative monitoring of solid-phase peptide synthesis by the ninhydrin reaction. Anal. Biochem. 117 (1981) 147-157.
34. M. Jackson and H. Mantsch, Halogenated alcohols as solvents for proteins: FTIR spectroscopic studies, Biochim. Biophys. Acta 1118 (1992) 139-143.
35. R. Nellore, Structural stability and in vitro biological activity of proteins during microencapsulation into biodegradable polymers (microspheres), Diss. Abstr. Int. B: 56 (1995) 1960.
36. R. Nellore and H. Bhagat, Structural and biological stability of a model protein, ribonuclease A, during microencapsulation, Pharm. Res. 11 (1994) S-314.
37. H. Joshi, V. Stella and E. Topp, Drug release from membranes of hyaluronic acid and its esters, J. Control. Rel. 20 (1992) 109-122.
38. H. Joshi and E. Topp, Hydration in hyaluronic acid and its esters using differential scanning calorimetry. Int. J. Pharm. 80 (1992) 213-225.
39. K. Sung and E. Topp, Effect of drug hydrophilicity and membrane hydration on diffusion in hyaluronic acid ester membranes, J. Control. Rel. 37 (1995) 95-104.
40. K. Sung and E. Topp, Swelling properties of hyaluronic acid ester membranes, J. Membr. Sci. 92 (1994) 157-167.
41. H. Yasuda and C. Lamaze, Permselectivity of solutes in homogeneous water-swollen polymer membranes, J. Macromol. Sci. Phys. B5 (1971) 111-134.